Risultati per: Sarcopenia: la prevenzione, il sospetto, la diagnosi e le azioni per il medico di medicina generale

Sperimentato a Bologna e a Barcellona da giugno

In Italia 5 mln di pazienti. Gemmato, ‘migliori cure e risparmi’. Locatelli, ‘curare la persona e non solo la malattia’

In Italia 5 mln di pazienti. Gemmato,

Fondazione Telethon tra le organizzazioni

Funerali a Gemona del professionista. Il ricordo di Sinagra

Funerali a Gemona del professionista. Il ricordo di Sinagra

Solo l’1% delle ricerche sono dedicate a condizioni specifiche di genere. Intervista alla neuroscienziata Antonella Santuccione Chadha: «Donne enorme bacino di pazienti sottodiagnosticato»

E’ una condizione genetica ereditaria che aumenta il rischio di malattia oncologica

Sesti (Simi), ‘intercetta precocemente i soggetti a rischio. Cure più tempestive’

Settimana mondiale. Iapb, liste attesa per visite troppo lunghe

Per una migliore qualità di vita. Corsi gratuiti, cultura e sport oltre alle terapie

Fnomceo, “i modelli organizzativi tengano conto di questa realtà”

Objective
This review aims to provide an estimate of sarcopenia prevalence and its impact on clinical characteristics in patients with systemic sclerosis (SSc).

Design
Systematic review and meta-analysis.

Data sources
Embase, Medline, Web of Science and the Cochrane Central Register of Controlled Trials were systemically searched from inception to 24 May 2023.

Eligibility criteria for selecting studies
We included observational studies that reported the prevalence of sarcopenia in patients with SSc.

Data extraction and synthesis
Two reviewers independently performed study selection and data extraction using standardised methods. Risk of bias was assessed using the Agency for Healthcare Research and Quality Scale and the Newcastle–Ottawa Scale. Meta-analysis was conducted using random effects models.

Results
A total of 4583 articles were screened and 9 studies with data from 815 patients were included in the analysis (8 cross-sectional studies and 1 retrospective cohort study). The overall prevalence of sarcopenia in patients with SSc was 22% (95% CI 17% to 28%). Patients with SSc with sarcopenia had a poorer quality of life (mean difference –12.02; 95% CI –19.11 to –4.93) and higher C reactive protein (CRP) levels (standardised mean difference 0.67; 95% CI 0.35 to 1.00).

Conclusions
Sarcopenia is common in patients with SSc. Patients with SSc with sarcopenia had a worse quality of life and higher CRP levels, based on our findings. Given the detrimental impact of sarcopenia on quality of life, future efforts aimed at early identification of sarcopenia in the clinical assessment of patients with SSc may have significance.

PROSPERO registration number
CRD42022368326.

Oggi c’è carenza di medici per la cattiva programmazione e il picco dei pensionamentiDal 2034 in poi crollano le uscite e la maxi offerta di nuovi dottori può trasformarsi in una pletora